Spinal cord injury (SCI) is a serious problem that primarily affects younger and middle-aged
adults at its onset. To date, no effective regenerative treatment has been developed. Over …

Advances in biomaterial synthesis and fabrication, stem cell biology, bioimaging,
microsurgery procedures, and microscale technologies have made minimally invasive …

The individual approaches of regenerative medicine efforts alone and rehabilitation efforts
alone have not yet fully restored function after severe spinal cord injury (SCI). Regenerative …

Neurological and functional recovery is limited following central nervous system injury and
severe injury to the peripheral nervous system. Extracellular matrix (ECM)‐mimetic …

In the field of drug delivery, the most commonly used treatments have traditionally been
systemically delivered using oral or intravenous administration. The problems associated …

Spinal cord injury (SCI) treatment requires a nanosystem for drug delivery that can
effectively penetrate the blood–spinal cord barrier (BSCB). Herein, we designed poly (2 …

Spinal cord injury (SCI) is a traumatic lesion that diminishes sensory and/or motor neuronal
functionality, directly affecting the quality of the patient's life. Due to the central nervous …

Dysfunctional clinical outcomes following spinal cord injury (SCI) result from glial scar
formation, leading to the inhibition of new axon growth and impaired regeneration …

Magnetic fiber composites combining superparamagnetic iron oxide nanoparticles (SPIONs)
and electrospun fibers have shown promise in tissue engineering fields. Controlled grafting …

Spinal cord injury (SCI) causes severe motor or sensory damage that leads to long-term
disabilities due to disruption of electrical conduction in neuronal pathways. Despite current …